Clinical Trial Update: A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Brenipatide for moderate-to-severe Alcohol Use Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alcohol Use Disorder | Phase 3 | Status: RECRUITING